| NIJ | Name: | 3-(3-fluorophenyl)-N-(4-methylpyridin-3-yl)propanamide | Formula: | C15 H15 F N2 O | SMILES: | O=C(Nc1cnccc1C)CCc1cccc(F)c1 | InChi: | InChI=1S/C15H15FN2O/c1-11-7-8-17-10-14(11)18-15(19)6-5-12-3-2-4-13(16)9-12/h2-4,7-10H,5-6H2,1H3,(H,18,19) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 3-(3-fluorophenyl)-N-(4-methylpyridin-3-yl)propanamide |
|
| NIY | Name: | META-NITRO-TYROSINE | Formula: | C9 H10 N2 O5 | SMILES: | O=[N+]([O-])c1cc(ccc1O)CC(C(=O)O)N | InChi: | InChI=1S/C9H10N2O5/c10-6(9(13)14)3-5-1-2-8(12)7(4-5)11(15)16/h1-2,4,6,12H,3,10H2,(H,13,14)/t6-/m0/s1 | Definition date: | 2001-10-24 | Last modified: | 2023-11-03 | Identifier: | 3-nitro-L-tyrosine |
|
| NJE | Name: | N-(4-methylpyridin-3-yl)-2-(piperidin-1-yl)acetamide | Formula: | C13 H19 N3 O | SMILES: | O=C(CN1CCCCC1)Nc1cnccc1C | InChi: | InChI=1S/C13H19N3O/c1-11-5-6-14-9-12(11)15-13(17)10-16-7-3-2-4-8-16/h5-6,9H,2-4,7-8,10H2,1H3,(H,15,17) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(4-methylpyridin-3-yl)-2-(piperidin-1-yl)acetamide |
|
| 3MY | Name: | 3-chloro-D-tyrosine | Formula: | C9 H10 Cl N O3 | SMILES: | Clc1cc(ccc1O)CC(C(=O)O)N | InChi: | InChI=1S/C9H10ClNO3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,11H2,(H,13,14)/t7-/m1/s1 | Definition date: | 2009-03-27 | Last modified: | 2023-11-03 | Identifier: | 3-chloro-D-tyrosine |
|
| NKU | Name: | 2-(1H-benzotriazol-1-yl)-N-[(3-chlorophenyl)methyl]-N-methylacetamide | Formula: | C16 H15 Cl N4 O | SMILES: | Clc1cccc(c1)CN(C)C(=O)Cn1nnc2ccccc21 | InChi: | InChI=1S/C16H15ClN4O/c1-20(10-12-5-4-6-13(17)9-12)16(22)11-21-15-8-3-2-7-14(15)18-19-21/h2-9H,10-11H2,1H3 | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(1H-benzotriazol-1-yl)-N-[(3-chlorophenyl)methyl]-N-methylacetamide |
|
| NLB | Name: | 6-(benzyloxy)-L-norleucine | Formula: | C13 H19 N O3 | SMILES: | O=C(O)C(N)CCCCOCc1ccccc1 | InChi: | InChI=1S/C13H19NO3/c14-12(13(15)16)8-4-5-9-17-10-11-6-2-1-3-7-11/h1-3,6-7,12H,4-5,8-10,14H2,(H,15,16)/t12-/m0/s1 | Definition date: | 2014-11-09 | Last modified: | 2023-11-03 | Release date: | 2015-02-11 | Identifier: | 6-(benzyloxy)-L-norleucine |
|
| NLE | Name: | NORLEUCINE | Formula: | C6 H13 N O2 | SMILES: | O=C(O)C(N)CCCC | InChi: | InChI=1S/C6H13NO2/c1-2-3-4-5(7)6(8)9/h5H,2-4,7H2,1H3,(H,8,9)/t5-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | L-norleucine |
|
| NLF | Name: | N-formyl-L-tryptophan | Formula: | C12 H12 N2 O3 | SMILES: | O=C(O)C(NC=O)Cc1c[NH]c2ccccc21 | InChi: | InChI=1S/C12H12N2O3/c15-7-14-11(12(16)17)5-8-6-13-10-4-2-1-3-9(8)10/h1-4,6-7,11,13H,5H2,(H,14,15)(H,16,17)/t11-/m0/s1 | Definition date: | 2022-04-05 | Last modified: | 2023-11-03 | Release date: | 2022-08-17 | Identifier: | N-formyl-L-tryptophan |
|
| NLO | Name: | O-METHYL-L-NORLEUCINE | Formula: | C7 H15 N O2 | SMILES: | O=C(OC)C(N)CCCC | InChi: | InChI=1S/C7H15NO2/c1-3-4-5-6(8)7(9)10-2/h6H,3-5,8H2,1-2H3/t6-/m0/s1 | Definition date: | 2004-01-27 | Last modified: | 2023-11-03 | Identifier: | methyl L-norleucinate |
|
| NLY | Name: | N-(4-aminobutyl)glycine | Formula: | C6 H14 N2 O2 | SMILES: | O=C(O)CNCCCCN | InChi: | InChI=1S/C6H14N2O2/c7-3-1-2-4-8-5-6(9)10/h8H,1-5,7H2,(H,9,10) | Definition date: | 2012-10-18 | Last modified: | 2023-11-03 | Release date: | 2013-10-09 | Identifier: | N-(4-aminobutyl)glycine |
|
| NMC | Name: | N-CYCLOPROPYLMETHYL GLYCINE | Formula: | C6 H11 N O2 | SMILES: | O=C(O)CNCC1CC1 | InChi: | InChI=1S/C6H11NO2/c8-6(9)4-7-3-5-1-2-5/h5,7H,1-4H2,(H,8,9) | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | N-(cyclopropylmethyl)glycine |
|
| NMI | Name: | 3-(1-methyl-1H-indol-3-yl)propanoic acid | Formula: | C12 H13 N O2 | SMILES: | O=C(O)CCc2c1ccccc1n(c2)C | InChi: | InChI=1S/C12H13NO2/c1-13-8-9(6-7-12(14)15)10-4-2-3-5-11(10)13/h2-5,8H,6-7H2,1H3,(H,14,15) | Definition date: | 2014-04-07 | Last modified: | 2023-11-03 | Release date: | 2014-06-18 | Identifier: | 3-(1-methyl-1H-indol-3-yl)propanoic acid |
|
| NMK | Name: | N-methyl Lysine | Formula: | C7 H17 N2 O2 | SMILES: | CN[CH](CCCC[NH3+])C(O)=O | InChi: | InChI=1S/C7H16N2O2/c1-9-6(7(10)11)4-2-3-5-8/h6,9H,2-5,8H2,1H3,(H,10,11)/p+1/t6-/m0/s1 | Definition date: | 2018-10-10 | Last modified: | 2023-11-03 | Release date: | 2019-01-16 | Identifier: | [(5~{S})-5-(methylamino)-6-oxidanyl-6-oxidanylidene-hexyl]azanium |
|
| NMM | Name: | (2S)-2-amino-5-[(N-methylcarbamimidoyl)amino]pentanoic acid | Formula: | C7 H16 N4 O2 | SMILES: | O=C(O)C(N)CCCNC(=[N@H])NC | InChi: | InChI=1S/C7H16N4O2/c1-10-7(9)11-4-2-3-5(8)6(12)13/h5H,2-4,8H2,1H3,(H,12,13)(H3,9,10,11)/t5-/m0/s1 | Synonyms: | L-NMMA | Definition date: | 2005-12-28 | Last modified: | 2023-11-03 | Identifier: | N~5~-(N-methylcarbamimidoyl)-L-ornithine |
|
| NO0 | Name: | 2-(3-ethynylphenyl)-N-(isoquinolin-4-yl)acetamide | Formula: | C19 H14 N2 O | SMILES: | C#Cc1cccc(c1)CC(=O)Nc1cncc2ccccc21 | InChi: | InChI=1S/C19H14N2O/c1-2-14-6-5-7-15(10-14)11-19(22)21-18-13-20-12-16-8-3-4-9-17(16)18/h1,3-10,12-13H,11H2,(H,21,22) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-ethynylphenyl)-N-(isoquinolin-4-yl)acetamide |
|
| 6ZS | Name: | L-isovaline | Formula: | C5 H11 N O2 | SMILES: | CC[C](C)(N)C(O)=O | InChi: | InChI=1S/C5H11NO2/c1-3-5(2,6)4(7)8/h3,6H2,1-2H3,(H,7,8)/t5-/m0/s1 | Definition date: | 2016-08-02 | Last modified: | 2023-11-03 | Release date: | 2017-10-04 | Identifier: | (2~{S})-2-azanyl-2-methyl-butanoic acid |
|
| NOI | Name: | 2-(3-chlorophenyl)-N-(1-methyl-1H-imidazol-5-yl)acetamide | Formula: | C12 H12 Cl N3 O | SMILES: | O=C(Nc1cncn1C)Cc1cccc(Cl)c1 | InChi: | InChI=1S/C12H12ClN3O/c1-16-8-14-7-11(16)15-12(17)6-9-3-2-4-10(13)5-9/h2-5,7-8H,6H2,1H3,(H,15,17) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-(1-methyl-1H-imidazol-5-yl)acetamide |
|
| 707 | Name: | N-(3-bromo-4-methoxybenzoyl)-beta-alanine | Formula: | C11 H12 Br N O4 | SMILES: | O=C(O)CCNC(c1cc(c(OC)cc1)Br)=O | InChi: | InChI=1S/C11H12BrNO4/c1-17-9-3-2-7(6-8(9)12)11(16)13-5-4-10(14)15/h2-3,6H,4-5H2,1H3,(H,13,16)(H,14,15) | Definition date: | 2015-09-11 | Last modified: | 2023-11-03 | Release date: | 2016-02-24 | Identifier: | N-(3-bromo-4-methoxybenzoyl)-beta-alanine |
|
| NOR | Name: | CYCLOHEXYL-NORSTATINE | Formula: | C13 H25 N O3 | SMILES: | O=C(OC(C)C)C(O)C(N)CC1CCCCC1 | InChi: | InChI=1S/C13H25NO3/c1-9(2)17-13(16)12(15)11(14)8-10-6-4-3-5-7-10/h9-12,15H,3-8,14H2,1-2H3/t11-,12+/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | propan-2-yl (2R,3S)-3-amino-4-cyclohexyl-2-hydroxybutanoate |
|
| NR0 | Name: | N-[(3R,4R)-4-aminooxolan-3-yl]-2-(6-amino-9H-purin-9-yl)-N-(2-oxoethyl)acetamide | Formula: | C13 H17 N7 O4 | SMILES: | OC(=O)CN(C1COCC1N)C(=O)Cn1cnc2c(N)ncnc21 | InChi: | InChI=1S/C13H17N7O4/c14-7-3-24-4-8(7)20(2-10(22)23)9(21)1-19-6-18-11-12(15)16-5-17-13(11)19/h5-8H,1-4,14H2,(H,22,23)(H2,15,16,17)/t7-,8-/m0/s1 | Definition date: | 2022-04-07 | Last modified: | 2023-11-03 | Release date: | 2023-04-05 | Identifier: | N-[(3R,4R)-4-aminooxolan-3-yl]-N-[(6-amino-9H-purin-9-yl)acetyl]glycine |
|
| NRC | Name: | methyl (2R)-2-(3-chlorophenyl)-3-[(4-methylpyridin-3-yl)amino]-3-oxopropanoate | Formula: | C16 H15 Cl N2 O3 | SMILES: | O=C(Nc1cnccc1C)C(c1cccc(Cl)c1)C(=O)OC | InChi: | InChI=1S/C16H15ClN2O3/c1-10-6-7-18-9-13(10)19-15(20)14(16(21)22-2)11-4-3-5-12(17)8-11/h3-9,14H,1-2H3,(H,19,20)/t14-/m1/s1 | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | methyl (2R)-2-(3-chlorophenyl)-3-[(4-methylpyridin-3-yl)amino]-3-oxopropanoate |
|
| NRG | Name: | N-OMEGA-NITRO-L-ARGININE | Formula: | C6 H13 N5 O4 | SMILES: | [O-][N+](=O)NC(=[N@H])NCCCC(C(=O)O)N | InChi: | InChI=1S/C6H13N5O4/c7-4(5(12)13)2-1-3-9-6(8)10-11(14)15/h4H,1-3,7H2,(H,12,13)(H3,8,9,10)/t4-/m0/s1 | Synonyms: | NNA | Definition date: | 1999-07-28 | Last modified: | 2023-11-03 | Identifier: | N~5~-(N-nitrocarbamimidoyl)-L-ornithine |
|
| NRL | Name: | N-[(3R,4R)-4-aminooxolan-3-yl]-N-[(4-amino-2-oxopyrimidin-1(2H)-yl)acetyl]glycine | Formula: | C12 H17 N5 O5 | SMILES: | OC(=O)CN(C1COCC1N)C(=O)CN1C=CC(N)=NC1=O | InChi: | InChI=1S/C12H17N5O5/c13-7-5-22-6-8(7)17(4-11(19)20)10(18)3-16-2-1-9(14)15-12(16)21/h1-2,7-8H,3-6,13H2,(H,19,20)(H2,14,15,21)/t7-,8-/m0/s1 | Definition date: | 2022-04-07 | Last modified: | 2023-11-03 | Release date: | 2023-04-05 | Identifier: | N-[(3R,4R)-4-aminooxolan-3-yl]-N-[(4-amino-2-oxopyrimidin-1(2H)-yl)acetyl]glycine |
|
| NRP | Name: | {4-[(4-hydroxyphenyl)methylidene]-2-[(1E)-3-methylbutanimidoyl]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | Formula: | C17 H19 N3 O4 | SMILES: | O=C1C(N=C(C(=[N@H])CC(C)C)N1CC(=O)O)=C/c2ccc(O)cc2 | InChi: | InChI=1S/C17H19N3O4/c1-10(2)7-13(18)16-19-14(17(24)20(16)9-15(22)23)8-11-3-5-12(21)6-4-11/h3-6,8,10,18,21H,7,9H2,1-2H3,(H,22,23)/b14-8+,18-13+ | Synonyms: | CHROMOPHORE (LEU-TYR-GLY) | Definition date: | 2010-04-07 | Last modified: | 2023-11-03 | Identifier: | {(4E)-4-(4-hydroxybenzylidene)-2-[(1E)-3-methylbutanimidoyl]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
| NRQ | Name: | {(4Z)-4-(4-hydroxybenzylidene)-2-[3-(methylthio)propanimidoyl]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | Formula: | C16 H17 N3 O4 S | SMILES: | O=C1C(N=C(C(=[N@H])CCSC)N1CC(=O)O)=Cc2ccc(O)cc2 | InChi: | InChI=1S/C16H17N3O4S/c1-24-7-6-12(17)15-18-13(16(23)19(15)9-14(21)22)8-10-2-4-11(20)5-3-10/h2-5,8,17,20H,6-7,9H2,1H3,(H,21,22)/b13-8-,17-12- | Synonyms: | CHROMOPHORE (MET-TYR-GLY) | Definition date: | 2003-10-07 | Last modified: | 2023-11-03 | Identifier: | {(4Z)-4-[(4-hydroxyphenyl)methylidene]-2-[(1Z)-3-(methylsulfanyl)propanimidoyl]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|